Sinphar Pharmaceutical (Taiwan) Market Value
| 1734 Stock | TWD 31.55 0.20 0.64% |
| Symbol | Sinphar |
Sinphar Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinphar Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinphar Pharmaceutical.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Sinphar Pharmaceutical on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Sinphar Pharmaceutical Co or generate 0.0% return on investment in Sinphar Pharmaceutical over 90 days. Sinphar Pharmaceutical is related to or competes with Abnova Taiwan, YungShin Global, Phytohealth Corp, Wellell, and Everlight Chemical. ,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care food... More
Sinphar Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinphar Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinphar Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.8924 | |||
| Information Ratio | 0.1523 | |||
| Maximum Drawdown | 5.67 | |||
| Value At Risk | (1.42) | |||
| Potential Upside | 1.57 |
Sinphar Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinphar Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinphar Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Sinphar Pharmaceutical historical prices to predict the future Sinphar Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0371 | |||
| Jensen Alpha | 0.0371 | |||
| Total Risk Alpha | 0.1406 | |||
| Sortino Ratio | 0.1535 | |||
| Treynor Ratio | 0.3337 |
Sinphar Pharmaceutical Backtested Returns
At this stage we consider Sinphar Stock to be very steady. Sinphar Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.19, which indicates the firm had a 0.19 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Sinphar Pharmaceutical Co, which you can use to evaluate the volatility of the company. Please validate Sinphar Pharmaceutical's Risk Adjusted Performance of 0.0371, coefficient of variation of 2369.85, and Semi Deviation of 0.767 to confirm if the risk estimate we provide is consistent with the expected return of 0.16%. Sinphar Pharmaceutical has a performance score of 14 on a scale of 0 to 100. The entity has a beta of 0.0838, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sinphar Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sinphar Pharmaceutical is expected to be smaller as well. Sinphar Pharmaceutical right now has a risk of 0.85%. Please validate Sinphar Pharmaceutical coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if Sinphar Pharmaceutical will be following its existing price patterns.
Auto-correlation | 0.30 |
Below average predictability
Sinphar Pharmaceutical Co has below average predictability. Overlapping area represents the amount of predictability between Sinphar Pharmaceutical time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinphar Pharmaceutical price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current Sinphar Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Sinphar Pharmaceutical lagged returns against current returns
Autocorrelation, which is Sinphar Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sinphar Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Sinphar Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Sinphar Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sinphar Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sinphar Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sinphar Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sinphar Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Sinphar Pharmaceutical Lagged Returns
When evaluating Sinphar Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sinphar Pharmaceutical stock have on its future price. Sinphar Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sinphar Pharmaceutical autocorrelation shows the relationship between Sinphar Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Sinphar Pharmaceutical Co.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sinphar Stock Analysis
When running Sinphar Pharmaceutical's price analysis, check to measure Sinphar Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinphar Pharmaceutical is operating at the current time. Most of Sinphar Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinphar Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinphar Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinphar Pharmaceutical to your portfolios can decrease your overall portfolio volatility.